High Content & Phenotypic Screening 2017

Agenda Topics

• High Throughput Screening
• Image Analysis and Data Management
• Phenotypic and High Content Screening of 3D Models
• Phenotypic Drug Discovery
• Phenotypic Screening for New Targets

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Chris Bakal, Dynamical Cell Systems Team Leader, Institute of Cancer Research
Andrew Barlow, Field Application Specialist, Thermo Fisher Scientific
Alexander Baumann, Senior Director, DiscoveRx Corporation
Stephen Brown, RNAi Facility Screening Manager, Sheffield University
Davide Danovi, Director, Cell Phenotyping Platform, Kings College London
Anthony Davies, Director of Translational Cell Imaging, The Queensland University of Technology
Roy Edward, Director, Biostatus Ltd
Matthias Fassler, Scientific Account Manager, Genedata
Catherine Goh, Head of Product Development and Marketing, siTOOLs Biotech GmbH
Kamyar Hadian, Group Leader, Helmholtz Zentrum München
Michael Jackson, Senior Vice President, Drug Discovery and Development, Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute
Matthias Nees, Group Leader, University of Turku
Christopher Schofield, Group Leader/Investigator, GlaxoSmithKline
Anton Simeonov, Scientific Director, National Institutes of Health
Jacob Tesdorpf, Director, Perkin Elmer
Bob Van de Water, Professor, Leiden University
Armin Wolf, Professor/Director, Novartis Institutes for BioMedical Research
Wolfram-Hubertus Zimmermann, Professor, University Medical Center Goettingen